Telo Genomics Corp's market cap is currently ―. The company's EPS TTM is C$-0.045; its P/E ratio is -4.56; Telo Genomics Corp is scheduled to report earnings on May 29, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	C$ -835.14K	C$ -672.55K	C$ -854.87K	C$ -710.88K	C$ -639.21K
EBITDA	C$ -824.60K	C$ -662.24K	C$ -844.70K	C$ -701.88K	C$ -631.43K
Net Income Common Stockholders	C$ -835.14K	C$ -672.55K	C$ -854.87K	C$ -710.88K	C$ -639.21K
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	C$ 1.30M	C$ 1.98M	C$ 2.67M	C$ 727.58K	C$ 1.42M
Total Assets	C$ 1.53M	C$ 2.20M	C$ 2.93M	C$ 979.58K	C$ 1.63M
Total Debt	C$ 32.50K	C$ 32.50K	C$ 32.50K	C$ 40.00K	C$ 40.00K
Net Debt	C$ -1.26M	C$ -1.95M	C$ -2.64M	C$ -687.58K	C$ -1.38M
Total Liabilities	C$ 321.36K	C$ 221.14K	C$ 312.87K	C$ 163.77K	C$ 141.13K
Stockholders Equity	C$ 1.21M	C$ 1.98M	C$ 2.61M	C$ 815.81K	C$ 1.48M
Cash Flow	-
Free Cash Flow	C$ -682.63K	C$ -693.18K	C$ -673.24K	C$ -692.83K	C$ -765.31K
Operating Cash Flow	C$ -682.63K	C$ -690.38K	C$ -672.23K	C$ -664.84K	C$ -757.56K
Investing Cash Flow	-	C$ -2.80K	C$ -1.01K	C$ -27.99K	C$ -7.75K
Financing Cash Flow	-	C$ -2.28K	C$ 2.62M	-	C$ 60.00K

Currency in CAD

Telo Genomics Corp Earnings and Revenue History

Income Statement >

Telo Genomics Corp Debt to Assets

Balance Sheet >

Telo Genomics Corp Cash Flow

Cash Flow >

Telo Genomics Corp Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing